DIA-MS proteome analysis of formalin-fixed paraffin-embedded glioblastoma tissues

Anal Chim Acta. 2022 Apr 29:1204:339695. doi: 10.1016/j.aca.2022.339695. Epub 2022 Mar 12.

Abstract

Developments in quantitative proteomics and data-independent acquisition (DIA) methodology is enabling quantification of proteins in biological samples. Currently, there are a few reports on DIA mass spectrometry (MS) approaches for proteome analysis of formalin-fixed paraffin-embedded (FFPE) tissues. Therefore, to facilitate detection and quantification of immune- and glioblastoma (GBM)-relevant proteins from FFPE patient materials, we established a simple and precise DIA-MS workflow. We first evaluated different lysis buffers for their efficiency in protein extractions from FFPE GBM tissues. Our results showed that more than 1700 proteins were detected and over 1400 proteins were quantified from GBM FFPE tissue microdissections. GBM-relevant proteins (e.g., GFAP, FN1, VIM, and MBP) were quantified with high precision (median coefficient of variation <12%). In addition, immune-related proteins (e.g., ILF2, MIF, and CD38) were consistently detected and quantified. The strategy holds great potential for routinizing protein quantification in FFPE tissue samples.

Keywords: Data-independent acquisition; Formalin-fixed paraffin-embedded; Glioblastoma; Mass spectrometry; Quantitative proteomics.

MeSH terms

  • Formaldehyde / chemistry
  • Glioblastoma*
  • Humans
  • Paraffin Embedding / methods
  • Proteome* / metabolism
  • Tandem Mass Spectrometry / methods
  • Tissue Fixation / methods

Substances

  • Proteome
  • Formaldehyde